Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.5670
+0.0020 (0.35%)
May 1, 2026, 4:00 PM EDT - Market closed
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $12.14 million as of May 1, 2026. Its market cap has decreased by -26.12% in one year.
Market Cap
12.14M
Enterprise Value
7.65M
1-Year Change
-26.12%
Ranking
Category
Stock Price
$0.57
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $12.14M, a decrease of -63.64%. That is a compound annual growth rate of -46.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 12.10M | -18.17% |
| Dec 31, 2025 | 14.78M | -24.29% |
| Dec 31, 2024 | 19.53M | -41.52% |
| Sep 16, 2024 | 33.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioLineRx | 13.26M |
| Intensity Therapeutics | 13.24M |
| BioCardia | 12.47M |
| BioVie | 12.44M |
| Lunai Bioworks | 11.97M |
| CytoMed Therapeutics | 11.80M |
| Quoin Pharmaceuticals | 11.69M |
| CDT Equity | 11.30M |